Zydus Hydrocortisone Sodium Succinate for Injection
Hydrocortisone Sodium Succinate for Injection failed impurities and degradation specifications.
Hydrocortisone Sodium Succinate for Injection failed impurities and degradation specifications.
Tretinoin Cream USP, 0.05% failed impurities and degradation specifications.
3 productsLidocaine Ointment USP, 5% failed content uniformity specifications.
Fosfomycin Tromethamine Granules for Oral Solution failed impurities and degradation specifications.
Biospectra Tris/Tromethamine failed stability specifications.
Apheresis Platelets, PAS, Leukocytes Reduced were not tested for pH or platelet yield.
Orbi 20 Whitening Cream is contaminated with mercury.
2 productsParoxetine Extended-Release Tablets failed dissolution specifications.
Ranolazine Extended-Release Tablets fail dissolution specifications.
Olanzapine Tablets, USP 5 mg, failed impurities and degradation specifications.
Apheresis Platelets were distributed without testing for pH or platelet yield.
Chlorthalidone Tablets failed dissolution specifications.
Phytonadione Injectable Emulsion failed impurities and degradation specifications.
Fluphenazine HCl Elixir failed stability specifications.
12 productsGlutathione, Myer's Cocktail, and Tri-Immune Boost injectable vials may contain elevated endotoxin levels, which could cause significant medical events.
3 productsLidocaine Ointment USP, 5%, Speermint Flavor failed content uniformity specifications and assay specifications.
Fluphenazine Hydrochloride Tablets failed impurity specifications during stability testing.
Trokendi XR extended-release capsules failed dissolution specifications.
Mycophenolate Mofetil for injection fails dissolution specifications.
Pooled Cryoprecipitated AHF was not prepared in accordance with specifications.
Revcovi injection failed stability specifications for protein concentration profile.
Prasugrel Tablets, USP, 10mg failed dissolution specifications and stability testing.
Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced were not tested for pH and were distributed.
Paxil CR tablets failed dissolution specifications and stability testing acceptance criteria.
Ramipril Capsules USP, 10 mg, failed impurity specifications.
Clobetasol Propionate Cream USP, 0.05%, 60 g tube failed content uniformity specifications.
Glutathione 200 mg/mL sterile multidose vials have elevated bacterial endotoxin levels, which could cause significant medical events.
Acamprosate Calcium, Delayed-Release Tablets failed dissolution specifications.
Diovan (valsartan) 160 mg tablets failed dissolution specifications.
Mirabegron Extended-Release Tablets contain an impurity above specification.
Compounded glutathione vials have elevated bacterial endotoxin levels, which could cause fever, hypotension, inflammatory reactions, anaphylactic shock.
Apheresis Platelets, PAS, Leukocytes Reduced, Pathogen Reduced were distributed without platelet yield testing.
Proin ER tablets failed dissolution specifications, which can affect drug release.
Dabigatran Etexilate Capsules failed impurity and degradation specifications.
4 productsGlycopyrrolate Oral Solution failed impurities and degradation specifications due to an unidentified impurity.
3 productsAmlodipine and Olmesartan Medoxomil Tablets failed dissolution specifications, with Olmesartan Medoxomil content below specifications.
Trokendi XR, topiramate extended-release capsules failed dissolution specifications.
3 productsDabigatran etexilate capsules failed impurity and degradation specifications during stability testing.
2 productsApheresis Platelets, Leukocytes Reduced, Irradiated did not meet platelet yield specifications.
Nystatin Cream USP is subpotent, with low assay results from stability testing.
Fexofenadine Hydrochloride Tablets failed impurities and degradation specifications.
Apheresis Platelets, Leukocytes Reduced, Irradiated were labeled as leukocytes reduced but were not tested to verify white blood cell count.
Methohexital Sodium failed impurities and degradation specifications.
Medline Remedy Specialized Silicone Cream has formaldehyde levels exceeding specification.
Methohexital Sodium for Injection failed impurities and degradation specifications.
CGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
3 productsChlorthalidone Tablets fail dissolution specifications.
Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specification results total impurities.